CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation

Autor: Gordon, Max J., Tardi, Paul, Loriaux, Marc M., Spurgeon, Stephen E., Traer, Elie, Kovacsovics, Tibor, Mayer, Lawrence D., Tyner, Jeffrey W.
Zdroj: In Leukemia Research February 2017 53:39-49
Databáze: ScienceDirect
Externí odkaz: